P

Inventor

KUO GEE-HONG

US59 patents
⚠️ This page may combine multiple inventors who share the name “KUO GEE-HONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

26 patents
US7301050B2Nov 27, 2007

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

JANSSEN PHARMACEUTICA NV64 citations97
US7635718B2Dec 22, 2009

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

JANSSEN PHARMACEUTICA NV48 citations96
US7425649B2Sep 16, 2008

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

JANSSEN PHARMACEUTICA NV20 citations92
US7125878B2Oct 24, 2006

Substituted pyrroline kinase inhibitors

JANSSEN PHARMACEUTICA NV33 citations92
US7598292B2Oct 6, 2009

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

JANSSEN PHARMACEUTICA NV10 citations84
US7598416B2Oct 6, 2009

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

JANSSEN PHARMACEUTICA NV12 citations84
US7750048B2Jul 6, 2010

GPR40 agonists

JANSSEN PHARMACEUTICA NV15 citations82
US7678786B2Mar 16, 2010

Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol

JANSSEN PHARMACEUTICA NV8 citations82
US7928238B2Apr 19, 2011

1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors

JANSSEN PHARMACEUTICA NV7 citations81
US7524858B2Apr 28, 2009

Substituted pyrroline kinase inhibitors

JANSSEN PHARMACEUTICA NV6 citations73
US11014917B2May 25, 2021

5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators

JANSSEN PHARMACEUTICA NV0 citations62
US7786135B2Aug 31, 2010

Substituted pyrroline kinase inhibitors

JANSSEN PHARMACEUTICA NV2 citations62
US7781450B2Aug 24, 2010

Substituted pyrroline kinase inhibitors

JANSSEN PHARMACEUTICA NV2 citations62
US7705015B2Apr 27, 2010

Substituted pyrroline kinase inhibitors

JANSSEN PHARMACEUTICA NV2 citations62
US7205298B2Apr 17, 2007

Substituted triazine kinase inhibitors

JANSSEN PHARMACEUTICA NV6 citations62
US7015329B2Mar 21, 2006

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

JANSSEN PHARMACEUTICA NV4 citations62
US10662170B2May 26, 2020

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations52
US10131648B2Nov 20, 2018

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations52
US9790198B2Oct 17, 2017

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations52
US9724322B2Aug 8, 2017

4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs

JANSSEN PHARMACEUTICA NV0 citations52
US8008513B2Aug 30, 2011

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

JANSSEN PHARMACEUTICA NV0 citations52
US7875744B2Jan 25, 2011

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

JANSSEN PHARMACEUTICA NV0 citations52
US7498351B2Mar 3, 2009

4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs

JANSSEN PHARMACEUTICA NV1 citations52
US10696662B2Jun 30, 2020

5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators

JANSSEN PHARMACEUTICA NV0 citations51
US9012412B2Apr 21, 2015

Dual SGLT1/SGLT2 inhibitors

JANSSEN PHARMACEUTICA NV0 citations51
US9771375B2Sep 26, 2017

Indazole compounds useful as ketohexokinase inhibitors

JANSSEN PHARMACEUTICA NV0 citations50

KUO GEE-HONG

5 patents

STERLING WINTHROP INC

5 patents

ORTHO MCNEIL PHARM INC

5 patents

SANOFI SA

4 patents

STERLING DRUG INC

2 patents

SANOFI WINTHROP INC

1 patent

ORTH MCNEIL PHARMACEUTICAL INC

1 patent

ZHANG XUQING

1 patent

Showing the top 50 of 59 patents by PatentIndex Score.